Literature DB >> 12077180

A novel function of monomeric amyloid beta-protein serving as an antioxidant molecule against metal-induced oxidative damage.

Kun Zou1, Jian-Sheng Gong, Katsuhiko Yanagisawa, Makoto Michikawa.   

Abstract

Aggregated and oligomeric amyloid beta-protein (Abeta) is known to exhibit neurotoxicity. However, the action of Abeta monomers on neurons is not fully understood. We have studied aggregation state-dependent actions of Abeta and found an oligomer-specific effect of Abeta on lipid metabolism in neurons (Michikawa et al., 2001). Here, we show a novel function of monomeric Abeta1-40, which is the major species found in physiological fluid, as a natural antioxidant molecule that prevents neuronal death caused by transition metal-induced oxidative damage. Monomeric Abeta1-40, which is demonstrated by SDS-PAGE after treatment with glutaraldehyde, protects neurons cultured in a medium containing 1.5 microm Fe(II) without antioxidant molecules. Metal ion chelators such as EDTA, CDTA (trans-1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid), and DTPA (diethylenetriamine-N,N,N',N",N"-penta-acetic acid, an iron-binding protein, transferrin, and antioxidant scavengers such as catalase, glutathione, and vitamin E also inhibit neuronal death under the same conditions. Monomeric Abeta1-40 inhibits neuronal death caused by Cu(II), Fe(II), and Fe(III) but does not protect neurons against H2O2-induced damage. Monomeric Abeta1-40 inhibits the reduction of Fe(III) induced by vitamin C and the generation of superoxides and prevents lipid peroxidation induced by Fe(II). Abeta1-42 remaining as a monomer also exhibits antioxidant and neuroprotective effects. In contrast, oligomeric and aggregated Abeta1-40 and Abeta1-42 lose their neuroprotective activity. These results indicate that monomeric Abeta protects neurons by quenching metal-inducible oxygen radical generation and thereby inhibiting neurotoxicity. Because aggregated Abeta is known to be an oxygen radical generator, our results provide a novel concept that the aggregation-dependent biological effects of Abeta are dualistic, being either an oxygen radical generator or its inhibitor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077180      PMCID: PMC6757724     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma.

Authors:  A Kontush; C Berndt; W Weber; V Akopyan; S Arlt; S Schippling; U Beisiegel
Journal:  Free Radic Biol Med       Date:  2001-01-01       Impact factor: 7.376

2.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

Authors:  B A Yankner; L K Duffy; D A Kirschner
Journal:  Science       Date:  1990-10-12       Impact factor: 47.728

3.  The relationship between the aggregational state of the amyloid-beta peptides and free radical generation by the peptides.

Authors:  A Monji; H Utsumi; T Ueda; T Imoto; I Yoshida; S Hashioka; K Tashiro ; N Tashiro
Journal:  J Neurochem       Date:  2001-06       Impact factor: 5.372

Review 4.  Alzheimer's disease: a central role for amyloid.

Authors:  D J Selkoe
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

5.  Mechanochemical mechanism for peptidyl free radical generation by amyloid fibrils.

Authors:  C J Kay
Journal:  FEBS Lett       Date:  1997-02-24       Impact factor: 4.124

6.  The relationship between Abeta-associated free radical generation and Abeta fibril formation revealed by negative stain electron microscopy and thioflavine-T fluorometric assay.

Authors:  A Monji; H Utsumi; I Yoshida; S Hashioka; K Tashiro; N Tashiro
Journal:  Neurosci Lett       Date:  2001-05-18       Impact factor: 3.046

7.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

Authors:  X Huang; M P Cuajungco; C S Atwood; M A Hartshorn; J D Tyndall; G R Hanson; K C Stokes; M Leopold; G Multhaup; L E Goldstein; R C Scarpa; A J Saunders; J Lim; R D Moir; C Glabe; E F Bowden; C L Masters; D P Fairlie; R E Tanzi; A I Bush
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

8.  Quantitation of amyloid beta-protein (A beta) in the cortex during aging and in Alzheimer's disease.

Authors:  H Funato; M Yoshimura; K Kusui; A Tamaoka; K Ishikawa; N Ohkoshi; K Namekata; R Okeda; Y Ihara
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

9.  Apolipoprotein E4 induces neuronal cell death under conditions of suppressed de novo cholesterol synthesis.

Authors:  M Michikawa; K Yanagisawa
Journal:  J Neurosci Res       Date:  1998-10-01       Impact factor: 4.164

10.  Amyloid beta-protein affects cholesterol metabolism in cultured neurons: implications for pivotal role of cholesterol in the amyloid cascade.

Authors:  Jian-Sheng Gong; Naoya Sawamura; Kun Zou; Juro Sakai; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Neurosci Res       Date:  2002-11-01       Impact factor: 4.164

View more
  81 in total

Review 1.  Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Neurol       Date:  2010-05-05       Impact factor: 5.330

2.  Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection.

Authors:  Ashley I Bush; Colin L Masters; Rudolph E Tanzi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-23       Impact factor: 11.205

Review 3.  Pathological implications of cell cycle re-entry in Alzheimer disease.

Authors:  David J Bonda; Hyun-pil Lee; Wataru Kudo; Xiongwei Zhu; Mark A Smith; Hyoung-gon Lee
Journal:  Expert Rev Mol Med       Date:  2010-06-29       Impact factor: 5.600

4.  The effect of Cu(2+) and Zn(2+) on the Aβ42 peptide aggregation and cellular toxicity.

Authors:  Anuj K Sharma; Stephanie T Pavlova; Jaekwang Kim; Jungsu Kim; Liviu M Mirica
Journal:  Metallomics       Date:  2013-11       Impact factor: 4.526

Review 5.  The keystone of Alzheimer pathogenesis might be sought in Aβ physiology.

Authors:  D Puzzo; W Gulisano; O Arancio; A Palmeri
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

6.  Promotion of oxidative lipid membrane damage by amyloid beta proteins.

Authors:  Ian V J Murray; Michael E Sindoni; Paul H Axelsen
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

Review 7.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

Review 8.  Staying connected: synapses in Alzheimer disease.

Authors:  Hyoung-Gon Lee; Paula I Moreira; Xiongwei Zhu; Mark A Smith; George Perry
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

9.  Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia.

Authors:  Danielle Wilson; Ruth Peters; Karen Ritchie; Craig W Ritchie
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

10.  Abeta42-to-Abeta40- and angiotensin-converting activities in different domains of angiotensin-converting enzyme.

Authors:  Kun Zou; Tomoji Maeda; Atsushi Watanabe; Junjun Liu; Shuyu Liu; Ryutaro Oba; Yoh-ichi Satoh; Hiroto Komano; Makoto Michikawa
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.